うつ病におけるマイクロバイオータ-腸-脳軸:メカニズム、マイクロバイオータ標的介入、およびトランスレーショナルチャレンジ
Liang Zeng1, Siyu Zhang1, Ruoxi Liu1
1Department of Medical Microbiology, Xiangya School of Basic Medicine, Central South University, Changsha, Hunan, China, csu.edu.cn.
International journal of microbiology
|January 1, 2026
まとめ
腸内マイクロバイオータを標的とすることで、うつ病治療に革命が起こる可能性があります。新たな治療法は、バランスを回復し、このメンタルヘルスの課題と戦うためにマイクロバイオータ-腸-脳軸に焦点を当てています。
科学分野:
- 神経科学
- 微生物学
- 精神医学
背景:
- うつ病は依然として治療選択肢が限られている世界的なメンタルヘルスの危機です。
- マイクロバイオータ-腸-脳軸は、うつ病におけるその役割がますます認識されています。
研究 の 目的:
- うつ病におけるマイクロバイオータ-腸-脳軸の機能不全のメカニズムをレビューすること。
- うつ病に対する新規のマイクロバイオータ標的介入を評価すること。
主な方法:
- メカニズム研究および臨床試験の文献レビュー。
- 神経、免疫、および内分泌経路の分析。
- 新たな治療戦略の評価。
主要な成果:
- マイクロバイオータ-腸-脳軸の機能不全は、迷走神経シグナル伝達、神経炎症、およびHPA軸の調節不全を伴います。
- プロバイオティクス、食事療法、およびファージ療法などの介入が有望です。
- AI駆動型の個別化医療は、将来の治療の可能性を提供します。
結論:
- 腸内マイクロバイオータは、うつ病の有望な治療標的を表します。
- マイクロバイオータ-腸-脳軸の恒常性の回復は、うつ病の新規治療の鍵となります。
- さらなる研究により、メカニズムの洞察を臨床応用へと転換できます。
関連する概念動画
Depression: Overview
741
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
741
Depressive Disorders: Etiology
408
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
408
Microorganisms in Medicine and Therapeutics
911
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
911
Antidepressant Drugs: MAOIs and Other Agents
765
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
765
Irritable Bowel Syndrome I: Introduction
885
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
885


